Cargando…
Injectable Antiretroviral Drugs: Back to the Future
Current HIV treatment regimens provide sustained virologic suppression, at least partially restore the immune system and have limited side effects; however, they do not allow viral eradication and they are burdened by daily pill intake with a life-long commitment for the people living with HIV (PHIV...
Autores principales: | Berruti, Marco, Riccardi, Niccolò, Canetti, Diana, Lo Caputo, Sergio, Taramasso, Lucia, Di Biagio, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913057/ https://www.ncbi.nlm.nih.gov/pubmed/33540877 http://dx.doi.org/10.3390/v13020228 |
Ejemplares similares
-
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients
por: Riccardi, Niccolò, et al.
Publicado: (2019) -
Migrants and imported disease: Trends of admission in an Italian infectious disease ward during the migration crisis of 2015–2017
por: Del Puente, Filippo, et al.
Publicado: (2020) -
Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018) -
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia
por: Taramasso, Lucia, et al.
Publicado: (2019) -
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy
por: Taramasso, Lucia, et al.
Publicado: (2018)